Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Go back to Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 282.86 +14.93 (5.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.93 | 52 Week High | $196.47 | |||
| Open | $267.35 | 52 Week Low | $127.10 | |||
| Day High | $286.40 | P/E | 314.29 | |||
| Day Low | $263.28 | EPS | $0.90 | |||
| Volume | 2,271,390 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 323.75 +0.62 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.13 | 52 Week High | $141.32 | |||
| Open | $319.10 | 52 Week Low | $97.79 | |||
| Day High | $325.00 | P/E | 51.80 | |||
| Day Low | $317.71 | EPS | $6.25 | |||
| Volume | 566,729 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.57 +0.03 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $45.34 | |||
| Open | $5.60 | 52 Week Low | $15.92 | |||
| Day High | $5.74 | P/E | 2.39 | |||
| Day Low | $5.45 | EPS | $2.33 | |||
| Volume | 4,951,510 | |||||



